As of January 22, 2025, Idorsia (IDIA.SW) has a market cap of $0.17 billion USD. According to our data, Idorsia is ranked No.7254 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.17 B |
0.06%
|
Dec 30, 2024 | $0.17 B |
-61.12%
|
Dec 29, 2023 | $0.44 B |
-84.25%
|
Dec 30, 2022 | $2.79 B |
-28.00%
|
Dec 30, 2021 | $3.88 B |
-26.96%
|
Dec 30, 2020 | $5.31 B |
-13.62%
|
Dec 30, 2019 | $6.14 B |
84.59%
|
Dec 28, 2018 | $3.33 B |
-36.27%
|
Dec 29, 2017 | $5.22 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Rogers Corporation
ROG
|
$1.84 B |
9.797 M
|
USA
|
Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
Sanofi
SNY
|
$128.55 B |
0.003 M
|
France
|
GlaxoSmithKline
GSK
|
$68.38 B |
0.002 M
|
UK
|
Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
AbbVie
ABBV
|
$300.53 B |
0.002 M
|
USA
|
Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
-0.001 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$75.23 B |
1.245 B
|
USA
|
Teva Pharmaceutical Industries
TEVA
|
$25.08 B |
19.908 M
|
Israel
|
Market Cap | = | IDIA.SW Stock Price | * | IDIA.SW Shares Outstanding |
= | $0.91 | * | 0.19 B | |
= | $0.17 B |